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a  b  s  t  r  a  c  t
Lymphocytic  choriomeningitis  virus  (LCMV)  is  a rare  cause  of central  nervous  system  disease  in humans.
Screening  by  real-time  RT-PCR  assay  is  of  interest  in  the  case  of  aseptic  meningitis  of  unknown  etiology.
A speciﬁc  LCMV  real-time  RT-PCR  assay,  based  on  the  detection  of genomic  sequences  of the  viral
nucleoprotein  (NP),  was  developed  to assess  the  presence  of  LCMV  in  cerebrospinal  ﬂuids  (CSF)  sent  for
viral screening  to  a Swiss  university  hospital  laboratory.
A  10-fold  dilution  series  assay  using  a plasmid  containing  the  cDNA  of  the  viral  NP  of  the  LCMV  isolate
Armstrong  (Arm)  53b  demonstrated  the  high  sensitivity  of the  assay  with  a lowest  detection  limit  of
≤50  copies  per  reaction.  High  sensitivity  was  conﬁrmed  by  dilution  series  assays  in a  pool  of  human  CSF
using  four  different  LCMV  isolates  (Arm53b,  WE54,  Traub  and E350)  with  observed  detection  limits  ofrevalence ≤10  PFU/ml  (Arm53b  and  WE54)  and  1 PFU/ml  (Traub  and  E350).
Analysis  of  130 CSF  showed  no  cases  of  acute  infection.  The  absence  of  positive  cases  was  conﬁrmed
by  a published  PCR  assay  detecting  all Old  World  arenaviruses.
This  study  validates  a  speciﬁc  and  sensitive  real-time  RT-PCR  assay  for  the  diagnosis  of LCMV  infections.
Results  showed  that  LCMV  infections  are  extremely  rare  in  hospitalized  patients  western  in Switzerland.
© 2011 Elsevier B.V. All rights reserved.Lymphocytic choriomeningitis virus (LCMV), the prototypic
ember of the Arenaviridae family, was isolated from a fatal case
f aseptic meningitis during the St. Louis encephalitis epidemic in
933 (Armstrong and Lillie, 1934).
In nature, LCMV is maintained by congenital transmission
ithin infected populations of the mouse species Mus  domesticus
nd Mus  musculus. LCMV infects readily other rodents, including
amsters and guinea pigs. The LCMV carrier state is characterized
y persistent infection with high virus loads in serum and sev-
ral organs in the absence of a virus-speciﬁc immune response and
vert pathology. Humans are accidental hosts and the main route
f transmission is by contact with infected rodents that shed large
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oi:10.1016/j.jviromet.2011.06.018quantities of virus in nasal secretions, saliva, milk, semen, urine,
and feces.
Although human LCMV cases are observed throughout the year,
disease incidence increases in winter, due probably to the move-
ment of infected rodents indoors, thus increasing the risk of human
exposure (Barton et al., 1993). In immunocompetent adult indi-
viduals, LCMV infection is either asymptomatic or results in a
self-limiting febrile illness associated rarely with fatalities. Signs
and symptoms are largely non-speciﬁc, including fever, myalgia,
and malaise. Central nervous system involvement manifests as
headache and photophobia, associated with nausea or vomiting.
In most cases, infected individuals recover completely, but this
may  require several months. Severe aseptic meningitis or menin-
goencephalitis is observed only in a minority of cases (Barton
et al., 1993). Human-to-human transmission has been documented
through organ donation associated with severe disease in the
immunocompromised recipient (Fischer et al., 2006), and congeni-
tal infections leading to severe and irreversible brain (Barton et al.,
1993; Barton and Mets, 2001; Bonthius et al., 2007; Wright et al.,
logical
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997) and retinal (Bonthius et al., 2007; Mets et al., 2000) injury
ave been described.
Acute human LCMV infections are diagnosed generally by virus
solation from CSF and the use of serological testing or classical PCR
ssays (Park et al., 1997; Emonet et al., 2007) offer the possibility
o detect pre- and postnatal LCMV infections. More recently, SYBR
reen-based quantitative PCR assays were developed to quantify
CMV in infected mice (McCausland and Crotty, 2008; Emonet et al.,
007). Due to their higher sensitivity and speciﬁcity compared to
oth viral culture and immunoﬂuorescence-based detection meth-
ds, RT-PCR viral assays are favored for the diagnosis of viral
nfection in most routine laboratories.
A real-time RT-PCR assay with speciﬁc primers and probes
dapted to published LCMV sequences available was developed to
creen acute LCMV infections in CSF. The use of a speciﬁc probe has
he main advantage to increase the LCMV-speciﬁcity compared to
YBR Green PCR methods. Over a period of two years, all hospital-
zed pediatric cases and adults less than 25-years-old for whom a
creening for viral meningoencephalitis was required by the physi-
ian at the University of Geneva Hospitals were screened for LCMV
nfections using this real-time RT-PCR.
To identify primers and probes, conserved regions speciﬁc to
CMV were screened based on an extensive alignment of all LCMV
nd Old World arenavirus’s sequences available in Genbank in
ugust 2010, including all recently discovered arenaviruses (Briese
t al., 2009; Gunther et al., 2009; Palacios et al., 2008). This align-
ent allowed to pinpoint a conserved region within the viral
ucleoprotein (NP) gene. Primer pairs were designed to corre-
pond to the least number of combinations matching perfectly
ach distinct LCMV sequence. Therefore, the primers used in the
CR are constituted of a mix  of 9 and 8 selected forward and
everse primers, respectively (Fig. 1). Primers and probe (Eurogen-
ech, Seraing, Belgium) were screened by NCBI nucleotide BLAST
Altschul et al., 1990) to exclude any cross-reactions with human
ellular sequences and distantly related viruses. The probe was
abelled at the 5′ end with the 6-carboxyﬂuorescein (FAM) and at
he 3′ end with the BHQ1 black hole quencher. In brief, the viral
enome was extracted individually from 400 l of samples using
he NucliSENS easyMAG (bioMérieux, Geneva, Switzerland) nucleic
cid kit, according to the manufacturer’s instructions. In addi-
ion, 20 l of standardized canine distemper virus (CDV) of known
oncentration was added to each sample before extraction to con-
rol for intra- and inter-assay variability as previously described
Cordey et al., 2010). To remove a maximum of DNA contami-
ant in eluates, a DNAse treatment was done using the DNA-free
it (Ambion, Rotkreuz, Switzerland), according to the manufac-
urer’s instructions. This step was necessary for optimal sensitivity
n the presence of more than 5 ng/ml of human DNA in the sam-
le. The synthesis of cDNA was performed with random hexamers
Roche, Rotkreuz, Switzerland) at 42 ◦C using the Superscript II
everse Transcriptase (Invitrogen, Basel, Switzerland), according
o the manufacturer’s instructions. cDNA was ampliﬁed using a
aqMan® 7500 (Applied Biosystems, Rotkreuz, Switzerland) ther-
ocycler under the following cycling conditions: 95 ◦C for 9 min; 50
ycles of 15 s at 95 ◦C and 1 min  at 58 ◦C. After assessment of optimal
rimers/probe concentrations, the reaction was performed in 20 l
ontaining 1× TaqMan® Universal PCR Master Mix  (Applied Biosys-
ems), 0.2 M of each individual LCMV forward primer, 0.2 M of
ach individual LCMV reverse primer, 0.2 M of LCMV probe per
eaction, and 5 l of cDNA. Results were analyzed using the SDS 1.4
rogram (Applied Biosystems).
The analytical sensitivity of the LCMV real-time RT-PCR was
etermined using the mammalian expression plasmid pcAGGS
ontaining the cDNA of the NP derived from the LCMV isolate
rmstrong (Arm) 53b in 10-fold serial dilutions. The experiment
howed a linear range between 50 and 5 × 104 copies of input Methods 177 (2011) 118– 122 119
with the lowest limit of detection being ≤50 copies per reac-
tion (Fig. 2). Of note, 5 plasmid copies were detected only in
one of the triplicate wells. Sensitivity was assessed further using
crude stocks of the LCMV isolates LCMV-Arm53b, LCMV-WE54,
LCMV-Traub, and LCMV-E350 grown in BHK21 cells (Table 1)
which were diluted serially in a pool of human CSF negative for
LCMV. The four LCMV isolates showed low limits of detection in
plaque-forming units (PFU) determined by immunofocus assay
(≤10 PFU/ml for Arm53b, ≤10 PFU/ml for WE54, ≤1 PFU/ml for
Traub, and ≤1 PFU/ml for E350). Similarly, dilution series assays
performed in phosphate buffered saline showed a reproducible
detection limit of ≤1 PFU/ml for each LCMV isolate, thus suggest-
ing the presence of defective interfering particles, a well-known
phenomenon with LCMV (Martinez Peralta and Lehmann-Grube,
1983; Francis and Southern, 1988; Meyer and Southern, 1997).
In addition, the recently identiﬁed LCMV-Marseille strain super-
natant (Emonet et al., 2007) has also been tested positive. To assess
the potential speciﬁcity of this real-time RT-PCR, the genetically
more distant New World arenaviruses, Junin virus and Pichinde
virus isolates, as well as individual pcAGGS plasmids containing
the cDNA of the NP derived from Lassa virus, Machupo virus,
Tacaribe virus, Latino virus, and Whitewater Arroyo virus were
examined also (Table 1). Consistent with their phylogenetic dis-
tance from LCMV, none of these arenaviruses was detected by
the assay, except Lassa virus for which a weak cross-reaction was
observed at a very high concentration, although a minimum of
1 and 4 mismatches are present in the forward and the reverse
primer sets, respectively. This cross-reaction can be explained by
the extremely high sequence homology between Lassa and LCMV.
Therefore, cross-reaction events should be considered for samples
with CT (threshold value) values close to the limit of positivity
determined at 40 CT. Finally, a large panel of unrelated virus isolates,
including herpes simplex virus, varicella zoster virus, Epstein–Barr
virus, JC virus, measles virus, enterovirus and parechovirus, belong-
ing to other virus families known to lead potentially to meningitis
or meningoencephalitis complications, remained undetected with
the LCMV real-time RT-PCR.
All hospitalized pediatric cases and adults less than 25 years old
who  underwent a CSF screening with negative results for selected
viral infections (enterovirus, parechovirus, herpes simplex virus,
varicella zoster virus, Epstein–Barr virus, JC virus, and/or measles
virus) between October 2008 and September 2010 were assessed
for LCMV with the newly developed real-time RT-PCR assay.
Of a total of 130 CSF samples (56 female [43%]; 74 male [57%];
median age, 2 years old), 51 (39%) were collected in infants less
than 1-year-old. The clinical syndromes ranged from meningitis,
encephalitis, convulsions, and other central nervous system dis-
eases. The analysis covers two  winter seasons known to represent
the peak window period of infection.
None of the 130 CSF samples was found positive for LCMV. Since
the design of the speciﬁc LCMV primers and probe was based on the
available sequence information in Genbank at that time, the pres-
ence of yet unknown strains of LCMV circulating in rodents and
transmitted to humans cannot be ruled out. To address this issue,
a previously published pan-arenavirus RT-PCR (Vieth et al., 2007)
capable of detecting all currently known Old World arenavirus
species, including LCMV, Lassa virus, and Mobala virus, was used.
When applied to the 130 CSF samples, none was positive for LCMV,
similar to the results obtained with the speciﬁc LCMV real-time
RT-PCR assay described above.
This report describes the analytical validation of a LCMV real-
time RT-PCR assay allowing rapid detection of LCMV strains that
have been shown to infect humans.
Despite important efforts to contact most investigators with
documented cases of human LCMV infections over the last few
years, it was not possible to obtain such rare clinical samples due
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Fig. 1. Primers and probe for LCMV real-time RT-PCR assay. (a) Nineteen LCMV NP reference sequences indicated by their Genbank accession numbers (EU480452, EU480450,
DQ868487, DQ118959, M22138, DQ868485, DQ286931, AB261990, AB261991, FJ895883, FJ895884, FJ895882, AF325215, AF325214, DQ868483, DQ361065, AY847350,
M20869.1 and NC004294) were aligned with the MAFFT algorithm in the Geneious software package. Consensus was  established with 100% identical residue at each
position. Conserved residues are indicated by dots and polymorphic residues by their actual IUPAC code. The most conserved area, shown here as double stranded cDNA, was
used  as the target for the real-time RT-PCR assay. The primer sequences are boxed in strand-speciﬁc arrows. The forward primers (F1–F9) are on the coding (upper) strand
and  the reverse primers (R1–R8) are on the complementary (lower) strand. The probe is shown in bold fonts in the upper strand of the consensus sequence; capital letters
indicate LNA residues used to increase its melting temperature. LNA residues were positioned within this highly conserved area to limit the risk of false negativity with
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nnknown LCMV sequences. Numbers on top refer to the 5′ end of the primer/prob
CMV  phylogeny is depicted by the tree on the left-hand side pointing to each in
enotype is shown to the right of the accession number and refers to the primer na
o the very limited amount of CSF collected initially. Nevertheless,
erial dilutions of both Arm-derived plasmid and different LCMV
trains cultures in a pool of CSF conﬁrmed the high analytical sen-
itivity of the new assay with limits of detection reaching ≤50
opies per reaction and ≤10 or 1 PFU/ml, respectively, indicating potential high clinical sensitivity.
Irrespective of the PCR assay used (LCMV speciﬁc real-time
T-PCR and classical broad range arenavirus PCR), LCMV was
ot detected in any CSF samples over the study period. Thesetions within the NP open reading frame using the Armstrong strains as reference.
al reference sequence. Primer combination adapted to the ampliﬁcation of each
dicated in (b) (F, For; R, Rev).
results show the extremely low incidence of LCMV infections
leading to hospital admission for acute meningoencephalitis in
western Switzerland and conﬁrm previous prospective surveil-
lance investigations conducted elsewhere. For instance, Park et al.
(1997) found no positive case for LCMV among a total of 813
CSF samples collected over a one-year period at two  Birming-
ham (UK) hospitals. Only extensive serological studies at country
level may  reveal the prevalence of LCMV within the human
population.
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Table  1
Performance of the LCMV real-time RT-PCR for the detection of different LCMV and other arenavirus strains.
Strain L CMV  real-time RT-PCR Limit of detection Slope R2
LCMV-ARM53b Positive ≤10 PFU/ml (in CSF) 3.62 1
LCMV-WE54 Positive ≤10 PFU/ml (in CSF) 3.91 0.99
LCMV-Traub Positive ≤1 PFU/ml (in CSF) 3.87 1
LCMV-E350 Positive ≤1 PFU/ml (in CSF) 3.65 1
LCMV-Marseille Positive ND ND ND
Lassa  Weak positive cross-reaction (CT > 39) Tested for 104 plasmid copies/PCR
Tacaribe Negative Tested for 104 plasmid copies/PCR
Machupo Negative Tested for 104 plasmid copies/PCR
Latino Negative Tested for 104 plasmid copies/PCR
Whitewater Arroyo Negative Tested for 104 plasmid copies/PCR
Junin Negative Tested for 105 copies/ml (in plasma)
Pichinde Negative 
Fig. 2. Analytical sensitivity of the LCMV real-time RT-PCR assay. 10-Fold serial
dilutions of Armstrong-derived plasmid (5 × 104–5 × 101 copies per reaction) were
tested by real-time RT-PCR assay. The log of copy numbers is plotted versus the
threshold cycle (CT). Each dot represents the average of three independent exper-
iments. Of note, a dilution with 5 ×100 plasmid copies showed positive detection
in  only one single triplicate. It was not considered for slope calculation. Errors bars
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Ondicate standard deviations.
The real-time RT-PCR assay described here provides a sensitive
nd adapted tool for specialized clinical laboratories.
Although the current study did not reveal the presence of acute
CMV infection in children and young adults over the past two
ears in western Switzerland, potential infections should not be
verlooked as clinical complications related to LCMV have been
bserved in sporadic cases throughout the world (Asnis et al.,
010; Ceianu et al., 2008; Emonet et al., 2007; Sosa et al., 2009).
n addition, this real-time RT-PCR assay could be used in rodents,
articularly in pet shops, as they represent the principal LCMV
eservoir.
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